Effect of Akt on the function of esophageal squamous cancer cell Eca109 and the expression of vasculogenic mimicry-related genes

National Medical Journal of China

Volumn 92, Issue 36, 2012, Pages 2556-2560

  Ding, Zong Li ^a   Wang, Lu ^c   Zhu, Hong ^b   Ling, Ting Sheng ^b   Hao, Bo ^b   Shi, Rui Hua ^b  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c NONE

Author keywords

Esophageal neoplasms; Matrix metalloproteinase 2; RNA interference; Vasculogenic mimicry

Indexed keywords

GELATINASE A; LIPOCORTIN 5; LIPOSOME; MEMBRANE PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOGENIC MIMICRY PROTEIN;

APOPTOSIS; ARTICLE; ARTIFICIAL MEMBRANE; CANCER CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; COLONY FORMATION; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FLOW CYTOMETRY; IN VITRO STUDY; INHIBITION KINETICS; MOLECULAR DYNAMICS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; WESTERN BLOTTING;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 2; NEOVASCULARIZATION, PATHOLOGIC; PLASMIDS; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84869784300     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2012.36.011     Document Type: Article

References (14)

1. The World Health Report 1997 - conquering suffering, enriching humanity. World Health Forum, 1997, 18: 248-260.
2. Pisani P, Parkin DM, Bray F, et al. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer, 1999, 83: 18-29.
3. Forastiere A, Weber R, Ang K. Treatment of head and neck cancer. N Engl J Med, 2008, 358: 1076.
4. 2010, 90: 2713-2717.
5. Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 1997, 275: 1943-1947.
6. Zhang S, Zhang D, Sun B. Vasculogenic mimicry: current status and future prospects. Cancer Lett, 2007, 254: 157-164.
7. 2011, 33: 260-264.
8. Maniotis AJ, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol, 1999, 155: 739-752.
9. 2009, 89: 1106-1109.
10. Folberg R, Maniotis AJ. Vasculogenic mimicry. APMIS, 2004, 112: 508-525.
11. Seftor RE, Seftor EA, Koshikawa N, et al. Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry ofembryonic vasculogenesis by aggressive melanoma. Cancer Res, 2001, 61: 6322-6327.
12. Hess AR, Seftor EA, Seftor RE, et al. Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry. Cancer Res, 2003, 63: 4757-4762.
13. Lissitzky JC, Parriaux D, Ristorcelli E, et al. Cyclic AMP signaling as a mediator of vasculogenic mimicry in aggressive humanmelanoma cells in vitro. Cancer Res, 2009, 69: 802-809.
14. Hess AR, Seftor EA, Gruman LM, et al. VE-cadherin regulates EphA2 in aggressive melanoma cells through a novelsignaling pathway: implications for vasculogenic mimicry. Cancer Biol Ther, 2006, 5: 228-233.